Home / Resource Library / Venetoclax and ibrutinib: Two partners for the front-line treatment of chronic lymphocytic leukemia

Venetoclax and ibrutinib: Two partners for the front-line treatment of chronic lymphocytic leukemia

Review article of venetoclax combined with ibrutinib for treatment of CLL.